Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BRÆDSTRUP KLINIK FOR FYSIOTERAPI, AUTORISEREDE FYSIOTERAPEUTER ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   2.2% 2.3% 1.8% 1.8% 1.9% 2.1% 19.5% 19.2%   Credit score (0-100)   68 66 71 70 69 66 6 7   Credit rating   BBB BBB A A A A B B   Credit limit (kDKK)   0.0 0.0 0.6 1.0 0.3 0.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,833 2,734 2,761 3,713 3,824 3,655 0.0 0.0   EBITDA   524 489 721 972 799 820 0.0 0.0   EBIT   401 371 605 864 709 705 0.0 0.0   Pre-tax profit (PTP)   166.0 145.0 392.4 674.0 517.2 453.1 0.0 0.0   Net earnings   84.0 84.0 276.4 496.9 366.9 316.6 0.0 0.0   Pre-tax profit without non-rec. items   166 145 392 674 517 453 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   4,941 4,824 4,709 4,600 4,590 4,475 0.0 0.0   Shareholders equity total   240 214 490 737 604 520 45.4 45.4   Interest-bearing liabilities   5,161 5,069 4,418 4,087 4,018 3,819 0.0 0.0   Balance sheet total (assets)   5,804 5,810 5,778 5,563 5,217 4,936 45.4 45.4   Net Debt   5,146 5,068 4,414 3,916 4,003 3,789 -45.4 -45.4     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,833 2,734 2,761 3,713 3,824 3,655 0.0 0.0   Gross profit growth   26.4% -3.5% 1.0% 34.5% 3.0% -4.4% -100.0% 0.0%   Employees   5 6 5 7 8 7 0 0   Employee growth %   0.0% 20.0% -16.7% 40.0% 14.3% -12.5% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   5,804 5,810 5,778 5,563 5,217 4,936 45 45   Balance sheet change%   -6.6% 0.1% -0.6% -3.7% -6.2% -5.4% -99.1% 0.0%   Added value   524.0 489.0 721.3 972.4 817.2 820.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -246 -235 -232 -217 -100 -231 -4,475 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   14.2% 13.6% 21.9% 23.3% 18.5% 19.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   6.8% 6.5% 10.6% 15.3% 13.2% 13.9% 0.0% 0.0%   ROI %   7.6% 7.1% 12.0% 17.9% 15.1% 15.8% 0.0% 0.0%   ROE %   42.4% 37.0% 78.5% 81.0% 54.7% 56.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   4.1% 3.7% 8.5% 13.2% 11.6% 10.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   982.1% 1,036.4% 612.0% 402.7% 501.0% 462.0% 0.0% 0.0%   Gearing %   2,150.4% 2,368.7% 901.7% 554.7% 665.4% 733.8% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.7% 4.6% 4.6% 4.6% 4.8% 6.5% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.7 0.7 0.9 1.0 0.7 0.5 0.0 0.0   Current Ratio   0.7 0.8 0.9 1.0 0.7 0.6 0.0 0.0   Cash and cash equivalent   15.0 1.0 3.7 171.5 15.0 29.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -312.0 -301.0 -136.4 23.4 -270.2 -360.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   105 82 144 139 102 117 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   105 82 144 139 100 117 0 0   EBIT / employee   80 62 121 123 89 101 0 0   Net earnings / employee   17 14 55 71 46 45 0 0